This approach is more practical than waiting for clinical development of cancer because a shorter time is needed to obtain results, particularly with relatively slow-growing tumors such as prostate cancer. However, the use of intermediate endpoints is limited by their predictive ability; this is a d
โฆ LIBER โฆ
Biological markers in urologic cancer
โ Scribed by Dr. Paul H. Lange; Howard N. Winfield
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 1003 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Current and proposed biologic markers in
โ
David G. Bostwick; Rodolfo Montironi; Raymond Nagle; Thomas Pretlow; Gary Miller
๐
Article
๐
1992
๐
John Wiley and Sons
๐
English
โ 249 KB
Epidemiology and environmental factors i
โ
Alan S. Morrison
๐
Article
๐
1987
๐
John Wiley and Sons
๐
English
โ 338 KB
๐ 2 views
Urologic cancers include malignancies of the genital and the urinary organs of men, and the urinary organs of women. For men in the United States, urologic cancers account for about 25% of all new cases of cancer and about 15% of cancer deaths. For women, cancers of the urinary organs account for 4%
Sexuality and fertility in urologic canc
โ
Leslie R. Schover
๐
Article
๐
1987
๐
John Wiley and Sons
๐
English
โ 695 KB
Aspiration cytology in the staging of ur
โ
Francesco Piscioli; Pierantonio Scappini; Lucio Luciani
๐
Article
๐
1985
๐
John Wiley and Sons
๐
English
โ 726 KB
Tumor markers in prostate cancer
โ
Edward H. Cooper; Mel R. G. Robinson; Peter Whelan; Micheal A. Ferro
๐
Article
๐
1992
๐
John Wiley and Sons
๐
English
โ 508 KB
Biological markers as indicators of resp
โ
Maria Grazia Daidone; Silvia Veneroni; Elvira Benini; Gorana Tomasic; Danila Cor
๐
Article
๐
1999
๐
John Wiley and Sons
๐
French
โ 126 KB
๐ 2 views